$RLJ
RLJ Lodging Trust

2023 Q2 Form 10-Q Financial Statement

#000151133723000013 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $357.0M $314.5M $302.2M
YoY Change 8.01% 29.48% 26.92%
Cost Of Revenue $211.9M $201.0M $195.7M
YoY Change 11.2% 26.38% 27.4%
Gross Profit $145.1M $113.5M $106.5M
YoY Change 3.66% 35.36% 26.06%
Gross Profit Margin 40.65% 36.09% 35.25%
Selling, General & Admin $39.31M $38.30M $36.19M
YoY Change 8.3% 4.52% 2.25%
% of Gross Profit 27.09% 33.75% 33.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.93M $45.00M $44.53M
YoY Change -4.26% -3.99% -4.96%
% of Gross Profit 30.96% 39.64% 41.8%
Operating Expenses $84.24M $284.3M $80.72M
YoY Change -69.24% 17.19% -1.86%
Operating Profit $60.87M -$170.8M $25.80M
YoY Change -145.46% 7.59% 1046.16%
Interest Expense -$19.31M $24.13M -$19.15M
YoY Change -180.96% -1.75% -23.42%
% of Operating Profit -31.73% -74.24%
Other Income/Expense, Net $736.0K $849.0K $780.0K
YoY Change 2.08% -88.35% -19.17%
Pretax Income $42.08M $10.85M $7.179M
YoY Change 24.64% -171.03% -126.3%
Income Tax $357.0K $339.0K $379.0K
% Of Pretax Income 0.85% 3.12% 5.28%
Net Earnings $34.57M $10.65M $290.0K
YoY Change 4.86% -169.82% -101.05%
Net Earnings / Revenue 9.68% 3.38% 0.1%
Basic Earnings Per Share $0.22 $0.03
Diluted Earnings Per Share $0.22 $0.03 $0.00
COMMON SHARES
Basic Shares Outstanding 159.2M shares 162.6M shares 162.1M shares
Diluted Shares Outstanding 156.7M shares 160.1M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $476.9M $474.3M $481.3M
YoY Change -6.75% -0.98% -27.66%
Cash & Equivalents $476.9M $474.3M $481.3M
Short-Term Investments
Other Short-Term Assets $82.60M $76.62M $79.09M
YoY Change 37.45% 36.37% 136.86%
Inventory
Prepaid Expenses
Receivables $41.75M $41.18M $38.53M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $601.3M $592.1M $598.9M
YoY Change -1.83% 3.32% -17.93%
LONG-TERM ASSETS
Property, Plant & Equipment $4.289B $4.301B $4.317B
YoY Change 0.46% 0.06% -1.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.480M $7.260M $6.979M
YoY Change 7.98% 9.27% 7.01%
Other Assets $34.40M $31.24M $55.07M
YoY Change -22.32% -27.77% 13.48%
Total Long-Term Assets $4.331B $4.340B $4.379B
YoY Change 0.24% -0.2% -0.9%
TOTAL ASSETS
Total Short-Term Assets $601.3M $592.1M $598.9M
Total Long-Term Assets $4.331B $4.340B $4.379B
Total Assets $4.933B $4.932B $4.978B
YoY Change -0.01% 0.21% -3.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $126.9M $144.8M $155.9M
YoY Change -8.78% 11.4% 0.5%
Accrued Expenses $142.4M $127.3M $137.7M
YoY Change 1.58% -2.45% -3.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $288.6M $291.5M $308.3M
YoY Change 0.45% 8.49% 0.86%
LONG-TERM LIABILITIES
Long-Term Debt $2.219B $2.219B $2.218B
YoY Change 0.32% 0.39% -7.96%
Other Long-Term Liabilities $25.04M $27.90M $23.77M
YoY Change 34.76% 30.19% 18.57%
Total Long-Term Liabilities $2.244B $2.247B $2.241B
YoY Change 0.6% 0.67% -7.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $288.6M $291.5M $308.3M
Total Long-Term Liabilities $2.244B $2.247B $2.241B
Total Liabilities $2.546B $2.539B $2.550B
YoY Change 1.14% 1.51% -6.78%
SHAREHOLDERS EQUITY
Retained Earnings -$1.036B -$1.058B -$1.049B
YoY Change -0.88% -1.11% 0.26%
Common Stock $3.013B $3.036B $3.057B
YoY Change -1.38% -2.02% -1.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.386B $2.379B $2.415B
YoY Change
Total Liabilities & Shareholders Equity $4.933B $4.932B $4.978B
YoY Change -0.01% 0.21% -3.32%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $34.57M $10.65M $290.0K
YoY Change 4.86% -169.82% -101.05%
Depreciation, Depletion And Amortization $44.93M $45.00M $44.53M
YoY Change -4.26% -3.99% -4.96%
Cash From Operating Activities $95.10M $42.02M $52.85M
YoY Change -10.3% 308.3% 132.69%
INVESTING ACTIVITIES
Capital Expenditures $33.14M $32.63M $37.73M
YoY Change -222.4% -234.11% -129.44%
Acquisitions
YoY Change
Other Investing Activities -$44.00K $0.00 $22.00K
YoY Change -100.35% -100.0% -99.99%
Cash From Investing Activities -$33.18M -$32.63M -$37.71M
YoY Change 126.89% -433.31% -196.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -56.16M -$40.19M -18.41M
YoY Change -3.05% -81.01% 118.65%
NET CHANGE
Cash From Operating Activities 95.10M $42.02M 52.85M
Cash From Investing Activities -33.18M -$32.63M -37.71M
Cash From Financing Activities -56.16M -$40.19M -18.41M
Net Change In Cash 5.756M -$30.81M -3.264M
YoY Change -82.8% -83.92% -106.09%
FREE CASH FLOW
Cash From Operating Activities $95.10M $42.02M $52.85M
Capital Expenditures $33.14M $32.63M $37.73M
Free Cash Flow $61.96M $9.384M $15.12M
YoY Change -53.44% -72.9% -89.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001511337
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InvestmentIncomeInterest
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35169
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
RLJ LODGING TRUST
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-4706509
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3 Bethesda Metro Center, Suite 1000
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
CY2023Q1 dei City Area Code
CityAreaCode
301
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
280-7777
CY2023Q1 dei Security12b Title
Security12bTitle
Common Shares of beneficial interest, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
RLJ
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
159150293 shares
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4165843000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4180328000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
7260000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
6979000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
474332000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
481316000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
31244000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
55070000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
323000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
319000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
41178000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
38528000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135480000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
136915000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
76615000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
79089000 usd
CY2023Q1 us-gaap Assets
Assets
4931952000 usd
CY2022Q4 us-gaap Assets
Assets
4978225000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2219284000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2217555000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
144775000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
155916000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
27904000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23769000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
116193000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
117010000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11144000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
20707000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
19412000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
14622000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2538712000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2549579000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
328266000 usd
CY2023Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
328266000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
366936000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
366936000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
160077784 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
160077784 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162003533 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162003533 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1601000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1620000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3034682000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3054958000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1057939000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1049441000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34175000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
40591000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2379455000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2414664000 usd
CY2023Q1 us-gaap Minority Interest In Operating Partnerships
MinorityInterestInOperatingPartnerships
6264000 usd
CY2022Q4 us-gaap Minority Interest In Operating Partnerships
MinorityInterestInOperatingPartnerships
6313000 usd
CY2023Q1 us-gaap Minority Interest In Joint Ventures
MinorityInterestInJointVentures
7521000 usd
CY2022Q4 us-gaap Minority Interest In Joint Ventures
MinorityInterestInJointVentures
7669000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
13785000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
13982000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2393240000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2428646000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4931952000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4978225000 usd
CY2023Q1 us-gaap Revenues
Revenues
314503000 usd
CY2022Q1 us-gaap Revenues
Revenues
242899000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
200994000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
159039000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44996000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46865000 usd
CY2023Q1 rlj Real Estate Taxes Rent And Insurance
RealEstateTaxesRentAndInsurance
24648000 usd
CY2022Q1 rlj Real Estate Taxes Rent And Insurance
RealEstateTaxesRentAndInsurance
22513000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13656000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14134000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
20000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
62000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
284314000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
190000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
10514000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
242613000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
849000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7285000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3664000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
172000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
24130000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
24561000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1417000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10572000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15401000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
281000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
122000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10853000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15279000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
339000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-15469000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable
17000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable
-104000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable
NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
-148000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable
NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
-118000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10645000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15247000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6279000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6279000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4366000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21526000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159483268 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164179661 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160143748 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164179661 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
10514000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-15469000 usd
CY2023Q1 rlj Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives Net Of Tax
AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesNetOfTax
-6416000 usd
CY2022Q1 rlj Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives Net Of Tax
AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesNetOfTax
34193000 usd
CY2023Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 usd
CY2022Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-5866000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4098000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12858000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable
17000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable
-104000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable
NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
-148000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable
NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
-118000 usd
CY2023Q1 rlj Comprehensive Income Loss Attributableto Common Shareholders
ComprehensiveIncomeLossAttributabletoCommonShareholders
4229000 usd
CY2022Q1 rlj Comprehensive Income Loss Attributableto Common Shareholders
ComprehensiveIncomeLossAttributabletoCommonShareholders
13080000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2428646000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
10514000 usd
CY2023Q1 rlj Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives Net Of Tax
AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesNetOfTax
-6416000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6131000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-1889000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24537000 usd
CY2023Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
0 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6279000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
12930000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2393240000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2413867000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-15469000 usd
CY2022Q1 rlj Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives Net Of Tax
AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesNetOfTax
34193000 usd
CY2022Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-5866000 usd
CY2022Q1 rlj Contributionsfromanoncontrollinginterest
Contributionsfromanoncontrollinginterest
156000 usd
CY2022Q1 rlj Distribution To Joint Venture Partner
DistributionToJointVenturePartner
2589000 usd
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
0 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5555000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-1269000 usd
CY2022Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
0 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6279000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1507000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2420792000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
10514000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-15469000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1417000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44996000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46865000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1474000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1684000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1086000 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
403000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
5866000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
281000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
122000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5692000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5184000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2650000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6946000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4782000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4254000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8603000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-320000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4135000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1449000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-9563000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10900000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42018000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10291000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
34125000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
32634000 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
24334000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32634000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9791000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
200000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
95000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
94006000 usd
CY2022Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
24537000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1889000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1269000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6279000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6279000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8100000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1666000 usd
CY2023Q1 rlj Paymentsof Distributionson Operating Partnership Units
PaymentsofDistributionsonOperatingPartnershipUnits
40000 usd
CY2022Q1 rlj Paymentsof Distributionson Operating Partnership Units
PaymentsofDistributionsonOperatingPartnershipUnits
3000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
343000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2023Q1 rlj Cashreceivedfromanoncontrollinginterest
Cashreceivedfromanoncontrollinginterest
0 usd
CY2022Q1 rlj Cashreceivedfromanoncontrollinginterest
Cashreceivedfromanoncontrollinginterest
156000 usd
CY2023Q1 rlj Cash Paid To A Noncontrolling Interest
CashPaidToANoncontrollingInterest
0 usd
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
23 state
CY2022Q1 rlj Cash Paid To A Noncontrolling Interest
CashPaidToANoncontrollingInterest
2589000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40194000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-211650000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-30810000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-191568000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
536386000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
713869000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
505576000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
522301000 usd
CY2023Q1 rlj Operating Partnerships Unit Outstanding
OperatingPartnershipsUnitOutstanding
160849615 shares
CY2023Q1 rlj Direct And Indirect Ownership Interest In Operating Partnerships
DirectAndIndirectOwnershipInterestInOperatingPartnerships
0.995
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
97 property
CY2023Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
21400 room
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
97 property
CY2023Q1 rlj Real Estate Interests Numberof Joint Ventures
RealEstateInterestsNumberofJointVentures
1 joint_venture
CY2023Q1 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts in these financial statements have been reclassified to conform to the current year presentation with no impact to net income (loss) and comprehensive income, shareholders’ equity or cash flows.</span></div>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and the amounts of contingent assets and liabilities at the balance sheet date and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
993190000 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
992609000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
4055187000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
4040505000 usd
CY2023Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
761211000 usd
CY2022Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
745978000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5809588000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5779092000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1643745000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1598764000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4165843000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4180328000 usd
CY2023Q1 rlj Real Estate Depreciation Expense Excluding Discontinued Operations Expense
RealEstateDepreciationExpenseExcludingDiscontinuedOperationsExpense
45000000 usd
CY2022Q1 rlj Real Estate Depreciation Expense Excluding Discontinued Operations Expense
RealEstateDepreciationExpenseExcludingDiscontinuedOperationsExpense
46700000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1400000 usd
CY2023Q1 us-gaap Revenues
Revenues
314503000 usd
CY2022Q1 us-gaap Revenues
Revenues
242899000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2219284000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2217555000 usd
CY2023Q1 rlj Unamortized Debt Issuance Costs On Bonds
UnamortizedDebtIssuanceCostsOnBonds
10101000 usd
CY2022Q4 rlj Unamortized Debt Issuance Costs On Bonds
UnamortizedDebtIssuanceCostsOnBonds
10693000 usd
CY2023Q1 rlj Debt Instrument Number Of Extension Options
DebtInstrumentNumberOfExtensionOptions
2 option
CY2023Q1 rlj Unsecured Debt Gross
UnsecuredDebtGross
824656000 usd
CY2022Q4 rlj Unsecured Debt Gross
UnsecuredDebtGross
823662000 usd
CY2023Q1 rlj Unamortizeddebtissuancecostsontermloans
Unamortizeddebtissuancecostsontermloans
2975000 usd
CY2022Q4 rlj Unamortizeddebtissuancecostsontermloans
Unamortizeddebtissuancecostsontermloans
3126000 usd
CY2023Q1 rlj Debt Instrument Number Of Extension Options
DebtInstrumentNumberOfExtensionOptions
2 option
CY2023Q1 rlj Secured Debt Gross
SecuredDebtGross
408103000 usd
CY2022Q4 rlj Secured Debt Gross
SecuredDebtGross
408193000 usd
CY2023Q1 rlj Unamortizeddebtissuancecostsonmortgageloans
Unamortizeddebtissuancecostsonmortgageloans
399000 usd
CY2022Q4 rlj Unamortizeddebtissuancecostsonmortgageloans
Unamortizeddebtissuancecostsonmortgageloans
481000 usd
CY2022Q4 rlj Mortgage Loan In Cash Trap Event
MortgageLoanInCashTrapEvent
1 loan
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1474000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1684000 usd
CY2023Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
482000 usd
CY2022Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-44000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
24130000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
24561000 usd
CY2023Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
1050000000 usd
CY2022Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
1175000000 usd
CY2023Q1 us-gaap Interest Rate Cash Flow Hedge Derivative At Fair Value Net
InterestRateCashFlowHedgeDerivativeAtFairValueNet
37791000 usd
CY2022Q4 us-gaap Interest Rate Cash Flow Hedge Derivative At Fair Value Net
InterestRateCashFlowHedgeDerivativeAtFairValueNet
44688000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34200000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
40600000 usd
CY2023Q1 us-gaap Amount Of Ineffectiveness On Net Investment Hedges
AmountOfIneffectivenessOnNetInvestmentHedges
0 usd
CY2023Q1 us-gaap Amount Of Ineffectiveness On Net Investment Hedges
AmountOfIneffectivenessOnNetInvestmentHedges
0 usd
CY2022Q1 us-gaap Amount Of Ineffectiveness On Net Investment Hedges
AmountOfIneffectivenessOnNetInvestmentHedges
0 usd
CY2022Q1 us-gaap Amount Of Ineffectiveness On Net Investment Hedges
AmountOfIneffectivenessOnNetInvestmentHedges
0 usd
CY2023Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
24600000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2219284000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2217555000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q1 rlj Restricted Cash Reserves Escrows As Percentage Of Revenue Required To Be Maintained Minimum
RestrictedCashReservesEscrowsAsPercentageOfRevenueRequiredToBeMaintainedMinimum
0.030
CY2023Q1 rlj Restricted Cash Reserves Escrows As Percentage Of Revenue Required To Be Maintained Maximum
RestrictedCashReservesEscrowsAsPercentageOfRevenueRequiredToBeMaintainedMaximum
0.050
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
31200000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
55100000 usd
CY2023Q1 rlj Number Of Real Estate Properties Operated Under Management Agreements
NumberOfRealEstatePropertiesOperatedUnderManagementAgreements
96 hotel
CY2019Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
35 hotel
CY2023Q1 rlj Number Of Real Estate Properties Operated Under Franchise Agreements
NumberOfRealEstatePropertiesOperatedUnderFranchiseAgreements
59 hotel
CY2019Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
35 hotel
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24500000 usd
CY2023Q1 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
0.2806
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6828527 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15247000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6279000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6279000 usd
CY2023Q1 rlj Paymentsof Dividendson Unvested Restricted Shares
PaymentsofDividendsonUnvestedRestrictedShares
202000 usd
CY2022Q1 rlj Paymentsof Dividendson Unvested Restricted Shares
PaymentsofDividendsonUnvestedRestrictedShares
26000 usd
CY2023Q1 rlj Net Income Loss Available To Common Stockholders Basic Excluding Amounts Attributable To Unvested Restricted Shares
NetIncomeLossAvailableToCommonStockholdersBasicExcludingAmountsAttributableToUnvestedRestrictedShares
4164000 usd
CY2022Q1 rlj Net Income Loss Available To Common Stockholders Basic Excluding Amounts Attributable To Unvested Restricted Shares
NetIncomeLossAvailableToCommonStockholdersBasicExcludingAmountsAttributableToUnvestedRestrictedShares
-21552000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159483268 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164179661 shares
CY2023Q1 rlj Incremental Common Shares Attributable To Unvested Restricted Shares
IncrementalCommonSharesAttributableToUnvestedRestrictedShares
568125 shares
CY2022Q1 rlj Incremental Common Shares Attributable To Unvested Restricted Shares
IncrementalCommonSharesAttributableToUnvestedRestrictedShares
0 shares
CY2023Q1 rlj Incremental Performance Units Attributable T
IncrementalPerformanceUnitsAttributableT
92355 shares
CY2022Q1 rlj Incremental Performance Units Attributable T
IncrementalPerformanceUnitsAttributableT
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160143748 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164179661 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
474332000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479047000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
31244000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
43254000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
505576000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
522301000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
32252000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
33911000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
67000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4344000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3629000 usd
CY2023Q1 rlj Gross Proceedsfrom Saleof Real Estate Heldforinvestment
GrossProceedsfromSaleofRealEstateHeldforinvestment
0 usd
CY2022Q1 rlj Gross Proceedsfrom Saleof Real Estate Heldforinvestment
GrossProceedsfromSaleofRealEstateHeldforinvestment
35450000 usd
CY2023Q1 rlj Disposal Group Costof Dispositionof Property Plantand Equipment
DisposalGroupCostofDispositionofPropertyPlantandEquipment
0 usd
CY2022Q1 rlj Disposal Group Costof Dispositionof Property Plantand Equipment
DisposalGroupCostofDispositionofPropertyPlantandEquipment
599000 usd
CY2023Q1 rlj Noncash Divestiture Of Other Assets
NoncashDivestitureOfOtherAssets
0 usd
CY2022Q1 rlj Noncash Divestiture Of Other Assets
NoncashDivestitureOfOtherAssets
726000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
34125000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
15138000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1454000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001511337-23-000013-index-headers.html Edgar Link pending
0001511337-23-000013-index.html Edgar Link pending
0001511337-23-000013.txt Edgar Link pending
0001511337-23-000013-xbrl.zip Edgar Link pending
exhibit311-3312023.htm Edgar Link pending
exhibit312-3312023.htm Edgar Link pending
exhibit321-3312023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rlj-20230331.htm Edgar Link pending
rlj-20230331.xsd Edgar Link pending
Show.js Edgar Link pending
rlj-20230331_def.xml Edgar Link unprocessable
rlj-20230331_lab.xml Edgar Link unprocessable
rlj-20230331_pre.xml Edgar Link unprocessable
rlj-20230331_htm.xml Edgar Link completed
rlj-20230331_cal.xml Edgar Link unprocessable